| MGMT Status as a Clinical Biomarker in Glioblastoma | 2020/05/01 | English | 122 |
| DUBs, Hypoxia, and Cancer | 2019/10/01 | English | 119 |
| Oncogene-Directed Alterations in Cancer Cell Metabolism | 2016/07/01 | English | 117 |
| Ontogeny of Tumor-Associated Macrophages and Its Implication in Cancer Regulation | 2016/01/01 | English | 115 |
| Cancer Cachexia: More Than Skeletal Muscle Wasting | 2018/12/01 | English | 115 |
| Inflammatory Reprogramming with IDO1 Inhibitors: Turning Immunologically Unresponsive ‘Cold’ Tumors ‘Hot’ | 2018/01/01 | English | 114 |
| Exercise and the Hallmarks of Cancer | 2017/06/01 | English | 114 |
| Emerging Mechanisms by which EMT Programs Control Stemness | 2020/09/01 | English | 114 |
| Immune Priming of the Tumor Microenvironment by Radiation | 2016/11/01 | English | 114 |
| Advanced Prostate Cancer: Treatment Advances and Future Directions | 2020/08/01 | English | 112 |
| Promoter DNA Hypermethylation and Paradoxical Gene Activation | 2020/05/01 | English | 111 |
| Glycosylation and Integrin Regulation in Cancer | 2018/08/01 | English | 111 |
| The Emerging Role of Cdk5 in Cancer | 2016/10/01 | English | 111 |
| The Influence of Lung Microbiota on Lung Carcinogenesis, Immunity, and Immunotherapy | 2020/02/01 | English | 110 |
| RNA Splicing and Cancer | 2020/08/01 | English | 109 |
| Mouse versus Human Neutrophils in Cancer: A Major Knowledge Gap | 2017/02/01 | English | 108 |
| Tumor Functional Heterogeneity Unraveled by scRNA-seq Technologies | 2020/01/01 | English | 102 |
| Racial Differences in Cancer Susceptibility and Survival: More Than the Color of the Skin? | 2017/03/01 | English | 101 |
| Cell Cycle and Beyond: Exploiting New RB1 Controlled Mechanisms for Cancer Therapy | 2019/05/01 | English | 100 |
| Targeting BCL-2-like Proteins to Kill Cancer Cells | 2016/08/01 | English | 100 |
| Single-Cell Transcriptomic Analysis of Tumor Heterogeneity | 2018/04/01 | English | 98 |
| Autoantibodies: Opportunities for Early Cancer Detection | 2017/03/01 | English | 98 |
| Targeting PI3K Signaling in Combination Cancer Therapy | 2017/06/01 | English | 95 |
| B7-H3 in Cancer – Beyond Immune Regulation | 2018/06/01 | English | 95 |
| Fibroblasts Fuel Immune Escape in the Tumor Microenvironment | 2019/11/01 | English | 94 |
| Rise of the Machines: Advances in Deep Learning for Cancer Diagnosis | 2019/03/01 | English | 92 |
| Targeting RAS -mutant Cancers: Is ERK the Key? | 2015/11/01 | English | 90 |
| Tumour Cell Secretome in Chemoresistance and Tumour Recurrence | 2020/06/01 | English | 90 |
| Mitochondrial OXPHOS Induced by RB1 Deficiency in Breast Cancer: Implications for Anabolic Metabolism, Stemness, and Metastasis | 2017/11/01 | English | 89 |
| Exosomal PD-L1: Roles in Tumor Progression and Immunotherapy | 2020/07/01 | English | 88 |